EYEPOINT INC (EYPT:NASDAQ)
$14.28 0.09 (0.6342%)
Analysed EYEPOINT INC (EYPT:NASDAQ) News Sources
Arvinas (ARVN) Moves 6.9% Higher: Will This Strength Last?
02-04-2026
yahoo.com
EyePoint Pharmaceuticals Teases August Phase 3 Wet AMD Data for DURAVYU at RBC Ophthalmology Conference
25-03-2026
marketbeat.com
How The EyePoint (EYPT) Story Is Shifting With Phase 3 DME And Duravyu In Focus
21-03-2026
yahoo.com
EyePoint sues rival Ocular Therapeutix, alleging false claims about eye drug
20-03-2026
yahoo.com
This Fund Bought $28 Million of a Beaten-Down Immunotherapy Stock Last Quarter. What Should Long-Term Investors Know?
16-03-2026
fool.com
This $64 Million Biotech Exit Seemingly Missed a 77% One-Day Surge on Gilead Takeover Deal
16-03-2026
fool.com
Biotech Stock Up Nearly 300% Draws $68.7 Million Bet as Breast Cancer Drug Targets 2027 Launch
16-03-2026
fool.com
This Biotech Stock Up 700% Is Still a Top Holding Despite a $9.3 Million Sale Last Quarter
16-03-2026
fool.com
EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
16-03-2026
yahoo.com
This Biotech Stock Up Nearly 100% in a Year Has Drawn a New $20 Million Share Investment
15-03-2026
fool.com
What is the current price of EYEPOINT INC (EYPT:NASDAQ)?
The current price of EYEPOINT INC (EYPT:NASDAQ) is $14.28.
EYEPOINT INC (EYPT:NASDAQ) absolute price change since previous trading day?
The absolute price change of EYEPOINT INC (EYPT:NASDAQ) since the previous trading day is $0.09.
EYEPOINT INC (EYPT:NASDAQ) percentage price change since previous trading day?
The percentage price change of EYEPOINT INC (EYPT:NASDAQ) since the previous trading day is 0.6342%.
What is the most recent average sentiment score for EYEPOINT INC (EYPT:NASDAQ)?
The most recent average sentiment score for EYEPOINT INC (EYPT:NASDAQ) is 77 out of 100.
What is the most recent average sentiment for EYEPOINT INC (EYPT:NASDAQ)?
The most recent sentiment for EYEPOINT INC (EYPT:NASDAQ) is .
SEC-8K** Filing Available For EYEPOINT INC (EYPT:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.